These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 29057035)

  • 1. Sepsis-Induced Cardiomyopathy: Oxidative Implications in the Initiation and Resolution of the Damage.
    Tsolaki V; Makris D; Mantzarlis K; Zakynthinos E
    Oxid Med Cell Longev; 2017; 2017():7393525. PubMed ID: 29057035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic contribution of melatonin to the treatment of septic cardiomyopathy: A novel mechanism linking Ripk3-modified mitochondrial performance and endoplasmic reticulum function.
    Zhong J; Tan Y; Lu J; Liu J; Xiao X; Zhu P; Chen S; Zheng S; Chen Y; Hu Y; Guo Z
    Redox Biol; 2019 Sep; 26():101287. PubMed ID: 31386965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential mechanism of mitochondrial dysfunction in septic cardiomyopathy.
    Pan P; Wang X; Liu D
    J Int Med Res; 2018 Jun; 46(6):2157-2169. PubMed ID: 29637807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial Mechanisms in Septic Cardiomyopathy.
    Cimolai MC; Alvarez S; Bode C; Bugger H
    Int J Mol Sci; 2015 Aug; 16(8):17763-78. PubMed ID: 26247933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of Mitochondrial Disorders in Septic Cardiomyopathy.
    Durand A; Duburcq T; Dekeyser T; Neviere R; Howsam M; Favory R; Preau S
    Oxid Med Cell Longev; 2017; 2017():4076348. PubMed ID: 29201271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathomechanisms of myocardial dysfunction in sepsis.
    Lorigados CB; Soriano FG; Szabo C
    Endocr Metab Immune Disord Drug Targets; 2010 Sep; 10(3):274-84. PubMed ID: 20509838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial Injury and Targeted Intervention in Septic Cardiomyopathy.
    Tan Y; Chen S; Zhong J; Ren J; Dong M
    Curr Pharm Des; 2019; 25(18):2060-2070. PubMed ID: 31284854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress: a key contributor to diabetic cardiomyopathy.
    Khullar M; Al-Shudiefat AA; Ludke A; Binepal G; Singal PK
    Can J Physiol Pharmacol; 2010 Mar; 88(3):233-40. PubMed ID: 20393588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Septic Cardiomyopathy.
    Beesley SJ; Weber G; Sarge T; Nikravan S; Grissom CK; Lanspa MJ; Shahul S; Brown SM
    Crit Care Med; 2018 Apr; 46(4):625-634. PubMed ID: 29227368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactive oxygen species and insulin-resistant cardiomyopathy.
    Mellor KM; Ritchie RH; Delbridge LM
    Clin Exp Pharmacol Physiol; 2010 Feb; 37(2):222-8. PubMed ID: 19671065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dystrophic cardiomyopathy: amplification of cellular damage by Ca2+ signalling and reactive oxygen species-generating pathways.
    Jung C; Martins AS; Niggli E; Shirokova N
    Cardiovasc Res; 2008 Mar; 77(4):766-73. PubMed ID: 18056762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipopolysaccharide and sepsis-associated myocardial dysfunction.
    Balija TM; Lowry SF
    Curr Opin Infect Dis; 2011 Jun; 24(3):248-53. PubMed ID: 21378563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Septic cardiomyopathy: pathophysiology and potential new therapeutic approaches].
    Suzuki T; Sakai M; Yamashita S; Tomita K; Hattori Y
    Nihon Yakurigaku Zasshi; 2018; 151(3):111-116. PubMed ID: 29526919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Septic Heart: Current Understanding of Molecular Mechanisms and Clinical Implications.
    Martin L; Derwall M; Al Zoubi S; Zechendorf E; Reuter DA; Thiemermann C; Schuerholz T
    Chest; 2019 Feb; 155(2):427-437. PubMed ID: 30171861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress.
    Brenner DA; Jain M; Pimentel DR; Wang B; Connors LH; Skinner M; Apstein CS; Liao R
    Circ Res; 2004 Apr; 94(8):1008-10. PubMed ID: 15044325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Heart in sepsis : Molecular mechanisms, diagnosis and therapy of septic cardiomyopathy].
    Martin L; Derwall M; Thiemermann C; Schürholz T
    Anaesthesist; 2017 Jul; 66(7):479-490. PubMed ID: 28677016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sepsis, mitochondrial failure and multiple organ dysfunction.
    Duran-Bedolla J; Montes de Oca-Sandoval MA; Saldaña-Navor V; Villalobos-Silva JA; Rodriguez MC; Rivas-Arancibia S
    Clin Invest Med; 2014 Apr; 37(2):E58-69. PubMed ID: 24690420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of extracellular histones in the cardiomyopathy of sepsis.
    Kalbitz M; Grailer JJ; Fattahi F; Jajou L; Herron TJ; Campbell KF; Zetoune FS; Bosmann M; Sarma JV; Huber-Lang M; Gebhard F; Loaiza R; Valdivia HH; Jalife J; Russell MW; Ward PA
    FASEB J; 2015 May; 29(5):2185-93. PubMed ID: 25681459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction.
    Niederbichler AD; Hoesel LM; Westfall MV; Gao H; Ipaktchi KR; Sun L; Zetoune FS; Su GL; Arbabi S; Sarma JV; Wang SC; Hemmila MR; Ward PA
    J Exp Med; 2006 Jan; 203(1):53-61. PubMed ID: 16380509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced cardiomyocyte Ca(2+) cycling precedes terminal AV-block in mitochondrial cardiomyopathy Mterf3 KO mice.
    Andersson DC; Fauconnier J; Park CB; Zhang SJ; Thireau J; Ivarsson N; Larsson NG; Westerblad H
    Antioxid Redox Signal; 2011 Nov; 15(9):2455-64. PubMed ID: 21381862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.